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Abstract
With the rapid development of large-scale high-throughput genotyping technology, genome-wide
association studies have become a popular approach to mapping genes underlying common human
disorders. Some genes are discovered, but many more have not been. Because these genes were
not initially identified, it is reasonable to assume that their main effect is weak. We propose a
method to accommodate such a situation. It is applied to the Genetic Analysis Workshop 16
Problem 1 case-control data in which shared-epitope alleles of HLA-DRB1 show very strong
association with rheumatoid arthritis. Because some previous functional studies have reported
association of gene KCNB1 to rheumatoid arthritis, we evaluate whether the gene KCNB1
contributes to the genetics of rheumatoid arthritis in this data set. Fifteen single-nucleotide
polymorphisms from this gene were chosen. The association of KCNB1 gene to rheumatoid
arthritis seems to be moderate.
Background
Conventional methods such as linear regression and
logistic regression are widely used in genetic association
tests in the presence of gene-gene or gene-environment
interaction. In recent years several new methods have
been developed. Based on Tukey’s non-additivity model,
Chatterjee et al. [1] proposed a model that makes use of
“generalized association parameters” to map additional
genes while allowing for gene-gene and gene-environ-
ment interactions. This method may have higher power
to detect genetic variants than some existing methods.
One drawback of their work is that it does not
accommodate the situation in which the main effect of
the second gene is bounded by constant times its
interaction effect with the first gene. To overcome this
drawback, Wang [2] proposed a method and derived the
asymptotic distribution of the likelihood-ratio test
statistic. This method allows the main effect of the
second gene to be bounded but does not assume it to be
zero. However, the method proposed by Wang is for a
continuous phenotype. In this report, we generalized
that method to case-control study so it can be applied to
the Genetic Analysis Workshop 16 (GAW16) Problem 1
data.
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Open AccessWe choose to study genes HLA-DRB1 using its shared-
epitope alleles and KCNB1. The relationship between
HLA-DRB1 and increased risk for rheumatoid arthritis
has been studied for 20 years, and several high risk
alleles of HLA-DRB1 are treated as shared-epitope alleles
[3,4], which are used widely in association study for
rheumatoid arthritis [5]. There are also some studies
covering regions including genes PTPN22 and TRAF-C5,
and at least two alleles of PTPN22 were associated with
increased risk for rheumatoid arthritis [6]. In a genome-
wide study, TRAF-C5 was found to be a risk locus for
rheumatoid arthritis [7]. Unlike PTPN22 and TRAF-C5,
which are supported by statistical evidence, there is some
functional evidence supporting the active role of KCNB1
in rheumatoid arthritis. The functional channel in
human T lymphocytes is composed of four identical
KCNB1 sub-units, and several peptide inhibitor of
KCNB1 have been developed as therapy for autoimmune
diseases [8] such as type 1 diabetes mellitus and
rheumatoid arthritis. An expression study [9] found
that there is a downregulation of potassium channels
including KCNB1 in autoimmune diseases.
Because the association signal of KCNB1 is not very
strong (it has not been discovered by other genome-wide
association studies), we conjecture that its effect may
mainly be manifested through its interaction with the
HLA-DRB1 gene. The goal of the current analysis is to
investigate whether the gene KCNB1, a previously
reported gene associated with rheumatoid arthritis, is
associated with rheumatoid arthritis in this GAW16
dataset. For this purpose, we use two statistical techni-
ques, including one particularly developed for this study,
which may be helpful in mapping genes that have weak
main effect.
Methods
The GAW16 Problem 1 data comes from the North
American Rheumatoid Arthritis Consortium (NARAC)
and includes 868 cases and 1194 controls. Single-
nucleotide polymorphisms (SNPs) of all individuals
were genotyped using 550 k Illumina chip (n = 545,080).
A genome-wide association scan based on the trend test
was performed to assess the association of all SNPs to
rheumatoid arthritis.
The regular logistic regression of two-locus disease
model with interaction is logit(π (x)|SE, SNP)=a0 +
a1 × SE + a2 × SNP + a3 × SE × SNP,w h e r eS Ei st h e
number of shared-epitope alleles of HLA-DRB1 and SNP
is the number of a chosen allele at an SNP of KCNB1,
and the coefficients a2 and a3 measure the additional
contribution of locus 2 over that of locus 1. A traditional
test of both effects with two degrees of freedom is used
to assess the association of the second locus, and the
hypotheses to be tested are H0: a2 = a3 =0v s .H1: a2 ≠ 0
or a3 ≠ 0. This test treats the coefficients a2 and a3 as
unrelated to each other because one of two coefficients
can be 0 regardless of the values of the other one.
However, this test may not be effective because the
values of a2 and a3 could depend on whether there is
association due to locus 2.
The situation of interest in this study is that main effect
|a2|, is constrained by the interaction |a3| effect. The
constraint is a3 ≠ 0, |a2| ≤ M ×| a3|, with M ap r e -
specified constant, and then the hypotheses to test in this
study are H0: a2 = a3 = 0 vs. H1 : a3 ≠ 0, |a2| ≤ M ×| a3|.
Based on this constraint, two extreme situations need to
be considered. When M is set to be 0, a2 has to be 0 as
well, and then the test measures interaction effect only
(H1 : a2 =0 ,a3 ≠ 0) with 1 df; when M is very large, a2 is
not affected by a3, and then the test measures both
effects (H1 : a2 ≠ 0o ra3 ≠ 0) with 2 df.
An appropriate value for M should achieve a balance
between measuring interaction only and both effects.
Based on some simulation results in linear regression
[2], when M is in the range of [0.1, 0.3], the asymptotic
quantiles of statistic based on this test seem to be rather
different from those of the interaction-only test and the
both-effects test. We set M to 0.4 in this analysis because
the value of M should reflect the moderate association of
KCNB1 and it should not be too small. Because the
distribution of the likelihood-ratio statistic of this
proposed test is unknown for case-control study, and
in order to compare p-values, the estimation of the
p-values need to be based on the same procedure. Ten
thousand permutations are used to estimate the p-values
in three tests for each SNP.
We also use principal-component analysis to test multi-
ple SNPs in KCNB1 jointly. The principal components
were obtained via the statistical package R (version
2.6.2) based on the correlation coefficient matrix.
Results
T h er e s u l to fag e n o m e - w i d ea s s o c i a t i o ns c a ni s
consistent with previous studies [8], with the strongest
signal coming from HLA region on 6p21. For genes HLA-
DRB1 and KCNB1,ap-value < 10
-100 for HLA-DRB1 and
the range of p-values for KCNB1 from 10
-4 to 10
-7 were
set as thresholds for significance.
KCNB1 (potassium voltage-gated channel, Shab-related
subfamily; member 1) is 110,667 bp long; mRNA is 3756
bp long and encodes a protein of 858 amino acids.
Position information comes from Homo sapiens
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36 SNPs available in KCNB1 for this dataset, rs1051295
(A/G) is located in 3’UTR and all others are located in
introns. The most significant 15 SNPs from this gene in
the initial scan were selected in subsequent analysis. The
first principal component accounts for about 80% of
variation for 15 SNPs. The proposed method was applied
to these 15 SNPs and the first component (Table 1). Also
presented in Table 1 are two tests: interaction effect only
test (H1 : a2 =0 ,a3 ≠ 0), and both effects test (H1 : a2 ≠ 0
or a3 ≠ 0). In Table 1, p-values show that the interaction-
effect-only test and the proposed test are more significant
than the both-effects test, and the overall strengths of
these two tests are similar. p-Values of six SNPs based on
the proposed test are smaller than those of interaction-
only test; p-values of four SNPs based on interaction-only
testaresmallerthanthoseoftheproposedtest;p-valuesof
two SNPs are the same. Because of limitation of the
number of permutations, p-values of three SNPs and the
first principal component cannot be compared (p-value <
0.0001).
Discussion
The association between HLA-DRB1 gene and rheuma-
toid arthritis is very strong. Except for some known
genes, a genome-wide scan found no other genes that
show obvious association. One possibility is that other
genes have a weak main effect, making them hard to
detect. We propose a method for case-control study that
allows the main effect of the second gene to be weak
relative to its interaction effect with the first gene. Using
this model, we studied the association between KCNB1
and rheumatoid arthritis.
The results of three tests used in this study support our
assumption that the effect of KCNB1 m a ym a i n l yb e
manifested through its interaction with the HLA-DRB1
gene.
The interaction-effect only test (M = 0) and the proposed
test (M = 0.4) perform better than the both-effects test;
for six SNPs, the proposed test even performs better than
interaction-effect-only test.
The M value reflects the strength of main effect in the
proposed model. M values of 0.1 and 0.4 represent small
effect and moderate effect, respectively. Considering the
moderate main effect of KCNB1,w es e tM value to be
0.4. The M value should be determined by researchers,
every gene has different M value. A wrongly chosen M
value will reduce the power in the test, so we suggest that
a rough range of M values should be determined by
some prior information, and then a number of intera-
tions be used to get the appropriate M value. Computing
burden is a big concern in case-control study. When the
number of permutations is larger than 10,000, compar-
isons cannot be made, so a more efficient algorithm for
permutation needs to be developed. This method is
more applicable in linear regression because the asymp-
totic distribution of the likelihood-ratio test statistic has
been derived [2].
Previous studies have reported association of rheuma-
toid arthritis to KCNB1 gene. Based on our analysis, the
association strength between KCNB1 and rheumatoid
arthritis seems to be moderate in the GAW16 Problem 1
data.
Conclusion
We used two methods, including one developed by us,
to investigate the association between KCNB1 gene and
rheumatoid arthritis. Based on results, the strength of the
Table 1: p-Values in three association tests based on 10,000 permutations
SNP ID Position function Interaction effect Both effects Proposed model
1 rsl051295 47,422,312 3'UTR 0.0008 0.0018 0.0008
2 rs2426154 47,435,402 intron 0.0011 0.0017 0.0008
3 rs237485 47,437,645 intron 0.0008 0.0015 0.0008
4 rs1961192 47,439,714 intron 0.0004 0.0005 0.0003
5 rs9636516 47,440,607 intron 0.0007 0.0017 0.0012
6 rs6063397 47,449,616 intron 0.0011 0.0023 0.0008
7 rs2057077 47,457,043 intron 0.0011 0.0017 0.0005
8 rs6067085 47,458,509 intron 0.0001 0.0011 0.0004
9 rs6090975 47,459,969 intron <0.0001 <0.0001 <0.0001
10 rs6125647 47,460,870 intron 0.0003 0.0004 <0.0001
11 rs926673 47,463,417 intron <0.0001 <0.0001 <0.0001
12 rs237462 47,466,610 intron 0.0019 0.0035 0.0021
13 rs237476 47,484,789 intron 0.0052 0.0102 0.0076
14 rs742758 47,495,219 intron <0.0001 <0.0001 <0.0001
15 rs572845 47,510,021 intron 0.0027 0.0022 0.0007
First principal component <0.0001 <0.0001 <0.0001
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